Published July 22, 2010
| Version v1
Journal article
Open
Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus
Creators
- 1. deCODE Genetics
- 2. University of Chicago
Description
We used an approach that we term ancestry-shift refinement mapping to investigate an association, originally discovered in a GWAS of a Chinese population, between rs2046210[T] and breast cancer susceptibility. The locus is on 6q25.1 in proximity to the C6orf97 and estrogen receptor α (ESR1) genes. We identified a panel of SNPs that are correlated with rs2046210 in Chinese, but not necessarily so in other ancestral populations, and genotyped them in breast cancer case:control samples of Asian, European, and African origin, a total of 10,176 cases and 13,286 controls. We found that rs2046210[T] does not confer substantial risk of breast cancer in Europeans and Africans (OR = 1.04, P = 0.099, and OR = 0.98, P = 0.77, respectively). Rather, in those ancestries, an association signal arises from a group of less common SNPs typified by rs9397435. The rs9397435[G] allele was found to confer risk of breast cancer in European (OR = 1.15, P = 1.2×10-3), African (OR = 1.35, P = 0.014), and Asian (OR = 1.23, P = 2.9×10-4) population samples. Combined over all ancestries, the OR was 1.19 (P = 3.9×10-7), was without significant heterogeneity between ancestries (Phet = 0.36) and the SNP fully accounted for the association signal in each ancestry. Haplotypes bearing rs9397435[G] are well tagged by rs2046210[T] only in Asians. The rs9397435[G] allele showed associations with both estrogen receptor positive and estrogen receptor negative breast cancer. Using early-draft data from the 1,000 Genomes project, we found that the risk allele of a novel SNP (rs77275268), which is closely correlated with rs9397435, disrupts a partially methylated CpG sequence within a known CTCF binding site. These studies demonstrate that shifting the analysis among ancestral populations can provide valuable resolution in association mapping.
Notes
Files
journal.pgen.1001029.pdf
Files
(2.9 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:c8c7ba664dfd83c2ec48afe9ca3d1bd5 |
369.1 kB | Preview Download |
|
md5:a04e050161f3cc12f3bd64ce0d97aa54
|
2.5 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.pgen.1001029
- Other
- oai:uchicago.tind.io:10902
Funding
- United States Army Medical Research and Materiel Command
- W81XWH-08-1-0740
- European Union
- 6th Framework Programme
- European Union
- 7th Framework Programme
- National Cancer Institute
- R01 CA89085
- National Cancer Institute
- P50 CA125183-03
- National Institutes of Health
- R01 CA122340
- National Cancer Institute
- Specialized Program of Research Excellence award